Replies to post #4440 on Momenta Pharmaceuticals, Inc. (MNTA)

[Bio_pete]

"My guess is it won't be mentioned during the upcoming earnings conference call TEVA has scheduled unless some analyst inquires.... "

If an analyst had any balls they would ask whether TEVA has filed a response to the minor deficiency letter. How can these analysts continue to predict approval in the 4th qtr if they don't even know whether TEVA has filed the response?